On ECHEMI
Home > Drugs > Neonatal hepatitis
Neonatal hepatitis
Neonatal hepatitis syndrome is a group of clinical syndromes that begin in the neonatal period, mainly manifested by persistent jaundice, increased serum bilirubin (direct bilirubin), obstructive jaundice, liver enlargement and liver function damage. Due to the large number of causes, it is difficult to determine the exact cause of each case, so it is often called neonatal hepatitis syndrome. Its main pathological change is the formation of nonspecific multinucleated giant cells.
  • Site of disease:

    liver
  • Infectious :

    Contagious
  • Frequent population:

    Newborns
  • Related symptoms:

    Gray face indigestion loss of appetite Taoqi infection liver depression and qi stagnation
  • Concurrent disease:

Related Drugs
Inosine Sodium Chloride Injection
Indication: Coenzyme drugs have the function of improving body metabolism. They are used as adjuvant treatment for leukopenia and thrombocytopenia caused by various reasons, heart failure, angina pectoris, hepatitis, etc. They can also be used as adjuvant treatment for optic atrophy and central retinitis.
Manufacturer:

Cisen Pharmaceutical Co., Ltd.

  • 1
  • 2
  • Go to Page Go
Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.